{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:05:18Z","timestamp":1786118718652,"version":"build-2736575974"},"reference-count":216,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1097\/rmr.0b013e31804c99d4","type":"journal-article","created":{"date-parts":[[2007,4,2]],"date-time":"2007-04-02T04:11:46Z","timestamp":1175487106000},"page":"219-242","source":"Crossref","is-referenced-by-count":37,"title":["Leukodystrophies"],"prefix":"10.1097","volume":"17","author":[{"given":"Gilles","family":"Lyon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviva","family":"Fattal-Valevski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin H.","family":"Kolodny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210213","first-page":"131","article-title":"Uber familiare diffuse sklerose (leukodystrophia cerebri progressiva hereditaria).","volume":"36","author":"Bielshowski","year":"1928","journal-title":"J Psychol Neurol"},{"key":"R2-2-20210213","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00019052-200404000-00017","article-title":"The latest on leukodystrophies.","volume":"17","author":"Schiffmann","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"R3-2-20210213","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/088307380101600908","article-title":"Clinical correlates of white-matter abnormalities on head magnetic resonance imaging.","volume":"16","author":"Lasbury","year":"2001","journal-title":"J Child Neurol"},{"key":"R4-2-20210213","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/ejpn.1999.0255","article-title":"Clinical characteristics of children with cerebral white matter abnormalities.","volume":"4","author":"Kristjansdottir","year":"2000","journal-title":"Eur J Paediatr Neurol"},{"key":"R5-2-20210213","first-page":"323","article-title":"Demyelinating diseases-new pathological insights, new therapeutic targets.","volume":"338","author":"Waxman","year":"1998","journal-title":"N Engl J Med"},{"key":"R6-2-20210213","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00004691-200101000-00006","article-title":"Epileptic seizures and electroencephalographic evolution in genetic leukodystrophies.","volume":"18","author":"Wang","year":"2001","journal-title":"J Clin Neurophysiol"},{"key":"R7-2-20210213","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1212\/WNL.50.6.1535","article-title":"The behavioral neurology of cerebral white matter.","volume":"50","author":"Filley","year":"1998","journal-title":"Neurology"},{"key":"R8-2-20210213","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1212\/WNL.54.8.1651","article-title":"Neuropsychological testing may predict early progression of asymptomatic adrenoleukodystrophy.","volume":"54","author":"Riva","year":"2000","journal-title":"Neurology"},{"key":"R9-2-20210213","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0887-8994(98)00015-0","article-title":"Transient visual symptoms as the initial manifestation of childhood adrenoleukodystrophy.","volume":"19","author":"Carmant","year":"1998","journal-title":"Pediatr Neurol"},{"key":"R10-2-20210213","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(06)70440-9","article-title":"Vanishing white matter disease.","volume":"5","author":"van der Knaap","year":"2006","journal-title":"Lancet Neurol"},{"key":"R11-2-20210213","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ana.410430213","article-title":"Quantitative magnetic resonance imaging of brain development in premature and mature newborns.","volume":"43","author":"Huppi","year":"1998","journal-title":"Ann Neurol"},{"key":"R12-2-20210213","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1542\/peds.107.3.593","article-title":"The necessity and difficulty of conducting magnetic resonance imaging studies on infant brain development.","volume":"107","author":"Peterson","year":"2001","journal-title":"Pediatrics"},{"key":"R13-2-20210213","first-page":"95","article-title":"Involvement of the pontomedullary corticospinal tracts: a useful finding in the diagnosis of X-linked adrenoleukodystrophy.","volume":"18","author":"Barkovich","year":"1997","journal-title":"AJNR Am J Neuroradiol"},{"key":"R14-2-20210213","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00005072-199909000-00001","article-title":"Abnormalities of developing white matter in lysosomal storage disease.","volume":"58","author":"Folkerth","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"R15-2-20210213","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2004.09.008","article-title":"White matter involvement in mitochondrial diseases.","volume":"84","author":"Lerman-Sagie","year":"2005","journal-title":"Mol Genet Metab"},{"key":"R16-2-20210213","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1469-8749.2004.tb00465.x","article-title":"White matter alterations associated with chromosomal disorders.","volume":"46","author":"Garcia-Cazoria","year":"2004","journal-title":"Dev Med Child Neurol"},{"key":"R17-2-20210213","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2005-865863","article-title":"Different molecular mechanisms leading to white matter hypomyelination in infantile onset lysosomal disorders.","volume":"36","author":"Di Rocco","year":"2005","journal-title":"Neuropediatrics"},{"key":"R18-2-20210213","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1007\/s00330-005-2846-2","article-title":"Diffusion-weighted MR imaging in leukodystrophies.","volume":"15","author":"Patay","year":"2005","journal-title":"Eur Radiol"},{"key":"R19-2-20210213","first-page":"1022","article-title":"Peroxisomal biogenesis disorder: comparison of conventional MR imaging with diffusion-weighted and diffusion-tensor imaging findings.","volume":"25","author":"ter Rahe","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"R20-2-20210213","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S031716710002713X","article-title":"Multimodal evoked potential studies in leukodystrophies of children.","volume":"15","author":"DeMeirleir","year":"1988","journal-title":"Can J Neurol Sci"},{"key":"R21-2-20210213","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1001\/jama.294.24.3131","article-title":"Adrenoleukodystrophy: new approaches to a neurodegenerative disease.","volume":"294","author":"Moser","year":"2005","journal-title":"JAMA"},{"key":"R22-2-20210213","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.nurx.2006.01.004","article-title":"Therapy of X-linked adrenoleukodystrophy.","volume":"3","author":"Moser","year":"2006","journal-title":"NeuroRx"},{"key":"R23-2-20210213","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/hmg\/ddi126","article-title":"Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy.","volume":"14","author":"Matzner","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R24-2-20210213","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/BF02057569","article-title":"Uber eine eigentimiliche form spastischer Lahmung mit Zerebralerscheiningen auf hereditarer Grundlage multiple sklerose.","volume":"16","author":"Pelizaeus","year":"1885","journal-title":"Arch Petit Nervenkt"},{"key":"R25-2-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02893591","article-title":"Eine eigenartige familiare Erkrankungsform (aplasia axialis extracorticalis congenita).","volume":"3","author":"Merzbacher","year":"1910","journal-title":"Z ges Neurol Psychiat"},{"key":"R26-2-20210213","first-page":"128","article-title":"Die Pelizaeus-Merzbacher'sche Krankheit. Klinische und anatomische Untersuchungen zum Problem ihrer Stellung inter den diffusen Sklerosen.","volume":"9","author":"Seitelberger","year":"1954","journal-title":"Wein Z Nhk"},{"key":"R27-2-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-004-0207-y","article-title":"PLP-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.","volume":"6","author":"Inoue","year":"2005","journal-title":"Neurogenetics"},{"key":"R28-2-20210213","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00005072-196404000-00008","article-title":"Pelizaeus-Merzbacher disease: a study in nosology.","volume":"23","author":"Zeman","year":"1964","journal-title":"J Neuropath Exp Neurol"},{"key":"R29-2-20210213","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.410210208","article-title":"Defective biosynthesis of proteolipid protein in Pelizaeus-Merzbacher disease.","volume":"21","author":"Koeppen","year":"1987","journal-title":"Ann Neurol"},{"key":"R30-2-20210213","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jns.2004.10.010","article-title":"Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system.","volume":"228","author":"Garbern","year":"2005","journal-title":"J Neurol Sci"},{"key":"R31-2-20210213","first-page":"579","article-title":"Deletion partielle de bras long du chromosome 18.","volume":"12","author":"de Grouchy","year":"1964","journal-title":"Pathol Biol"},{"key":"R32-2-20210213","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/(SICI)1096-8628(19970725)74:4<422::AID-AJMG14>3.0.CO;2-K","article-title":"Magnetic resonance imaging demonstrates incomplete myelination in 18q-syndrome: evidence for myelin basic protein haploinsufficiency.","volume":"74","author":"Gay","year":"1997","journal-title":"Am J Med Genet"},{"key":"R33-2-20210213","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00234-004-1309-9","article-title":"White-matter disease in 18 q-deletion (18q-) syndrome: magnetic resonance spectroscopy indicates demyelination or increased myelin turnover rather than dysmyelination.","volume":"47","author":"Hausler","year":"2005","journal-title":"Neuroradiology"},{"key":"R34-2-20210213","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1469-8749.1990.tb08435.x","article-title":"The brain in the 18q-syndrome.","volume":"32","author":"Vogel","year":"1990","journal-title":"Dev Med Child Neurol"},{"key":"R35-2-20210213","first-page":"860","article-title":"Molecular characterization of patients with 18q23 deletions.","volume":"60","author":"Strathdee","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R36-2-20210213","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1471-4159.1992.tb09316.x","article-title":"Morphometric analysis of normal, mutant and transgenic CNS: correlation of myelin basic protein expression to myelinogenesis.","volume":"58","author":"Shine","year":"1992","journal-title":"J Neurochem"},{"key":"R37-2-20210213","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/oxfordjournals.jhered.a109442","article-title":"Shiverer: an autosomal recessive mutant mouse with myelin deficiency.","volume":"72","author":"Chernoff","year":"1981","journal-title":"J Hered"},{"key":"R38-2-20210213","first-page":"895","article-title":"Molecular analysis of the 18q- syndrome- and correlation with phenotype.","volume":"52","author":"Kline","year":"1993","journal-title":"Am J Hum Genet"},{"key":"R39-2-20210213","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/brain\/72.3.373","article-title":"Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant.","volume":"72","author":"Alexander","year":"1949","journal-title":"Brain"},{"key":"R40-2-20210213","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/088307389300800205","article-title":"Alexander's disease: Clues to diagnosis.","volume":"8","author":"Pridmore","year":"1993","journal-title":"J Child Neurol"},{"key":"R41-2-20210213","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0887-8994(97)00128-8","article-title":"Adolescent case of Alexander disease: MR imaging and MR spectroscopy.","volume":"18","author":"Takanashi","year":"1998","journal-title":"Pediatr Neurol"},{"key":"R42-2-20210213","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0022-510X(99)00090-8","article-title":"Positron emission tomography in juvenile Alexander disease.","volume":"165","author":"Sawaishi","year":"1999","journal-title":"J Neurol Sci"},{"key":"R43-2-20210213","first-page":"541","article-title":"Alexander disease: diagnosis with MR imaging.","volume":"22","author":"van der Knaap","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"key":"R44-2-20210213","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1212\/01.wnl.0000198770.80743.37","article-title":"Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord.","volume":"66","author":"van der Knaap","year":"2006","journal-title":"Neurology"},{"key":"R45-2-20210213","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00005072-199805000-00067","article-title":"High molecular weight GFAP aggregates in Alexander's disease.","volume":"57","author":"Johnson","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"R47-2-20210213","first-page":"391","article-title":"Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice.","volume":"152","author":"Messing","year":"1998","journal-title":"Am J Pathol"},{"key":"R48-2-20210213","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1212\/01.wnl.0000200905.43191.4d","article-title":"Alexander disease. Not just a leukodystrophy anymore.","volume":"66","author":"Barkovich","year":"2006","journal-title":"Neurology"},{"key":"R49-2-20210213","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jnen\/60.6.563","article-title":"Alexander disease: new insights form genetics.","volume":"60","author":"Messing","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"R50-2-20210213","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/504411","article-title":"The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B- crystallin and HSP27.","volume":"79","author":"Der Perng","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R51-2-20210213","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/323799","article-title":"Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation.","volume":"69","author":"Rodriquez","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R52-2-20210213","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.bmt.1700871","article-title":"Allogenic bone marrow transplantation for Alexander's disease.","volume":"20","author":"Staba","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"R53-2-20210213","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/422763","article-title":"Mutations in the gene encoding gap junction protein 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease.","volume":"75","author":"Uhlenberg","year":"2004","journal-title":"Am J Hum Gent"},{"key":"R54-2-20210213","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1212\/01.wnl.0000223832.66286.e4","article-title":"GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy.","volume":"67","author":"Bugiani","year":"2006","journal-title":"Neurology"},{"key":"R55-2-20210213","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10048-006-0065-x","article-title":"A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease.","volume":"8","author":"Salviati","year":"2007","journal-title":"Neurogenetics"},{"key":"R56-2-20210213","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1212\/01.WNL.0000123094.13406.20","article-title":"Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF.","volume":"62","author":"Wolf","year":"2004","journal-title":"Neurology"},{"key":"R57-2-20210213","first-page":"1466","article-title":"New syndrome characterized by hypomyelination with atrophy of the basal ganglia and cerebellum.","volume":"23","author":"van der Knaap","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"R58-2-20210213","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng1870","article-title":"Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract.","volume":"38","author":"Zara","year":"2006","journal-title":"Nat Genet"},{"key":"R59-2-20210213","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1212\/01.WNL.0000158615.56071.E3","article-title":"Leukoencephalopathy with ataxia, hypodontia and hypomyelination.","volume":"64","author":"Wolf","year":"2005","journal-title":"Neurology"},{"key":"R60-2-20210213","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-2008-1071282","article-title":"Early onset leukodystrophy with distinct facial features in 2 siblings.","volume":"20","author":"Harbord","year":"1989","journal-title":"Neuropediatrics"},{"key":"R61-2-20210213","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ajmg.a.10019","article-title":"Leukodystrophy associated with oligodontia, in a large inbred family: Fortuitous association or new entity?","volume":"118A","author":"Atrouni","year":"2003","journal-title":"Am J Med Genet"},{"key":"R62-2-20210213","first-page":"157","article-title":"Canavan disease: a white matter disorder.","volume":"12","author":"Kumar","year":"2006","journal-title":"MRDD Research Reviews"},{"key":"R63-2-20210213","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/s-2008-1071487","article-title":"Megalencephaly with dysmyelination, spasticity, seizures and distinctive neurophysiological findings in two siblings.","volume":"21","author":"Harbord","year":"1990","journal-title":"Neuropediatrics"},{"key":"R64-2-20210213","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0387-7604(98)00002-3","article-title":"Megalencephaly and leukodystrophy with mild clinical course. A report on 12 new cases.","volume":"20","author":"Topu","year":"1998","journal-title":"Brain Dev"},{"key":"R65-2-20210213","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0887-8994(96)00048-3","article-title":"Megalencephalic leukodystrophy in an Asian Indian ethnic group.","volume":"14","author":"Singhal","year":"1996","journal-title":"Pediatr Neurol"},{"key":"R66-2-20210213","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ana.410370308","article-title":"Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children.","volume":"37","author":"van der Knaap","year":"1995","journal-title":"Ann Neurol"},{"key":"R67-2-20210213","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/088307389601100604","article-title":"Leukoencephalopathy, megalencephalopathy and mild clinical course. A recently individualized familial leukodystrophy. Report on five new cases.","volume":"11","author":"Goutieres","year":"1996","journal-title":"J Child Neurol"},{"key":"R68-2-20210213","first-page":"244","article-title":"Neuroimaging and clinically distinctive features in van der Knapp megalencephalic leukoencephalopathy.","volume":"3","author":"Besenski","year":"1997","journal-title":"Int J Neuroradiol"},{"key":"R69-2-20210213","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1093\/hmg\/ddh291","article-title":"Localization and functional analysis of the MLC1 protein involved in megalencephalic leukoencephalopathy with subcortical cysts.","volume":"13","author":"Teijido","year":"2004","journal-title":"Hum Mol Genet"},{"key":"R70-2-20210213","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/088307380001501010","article-title":"Siblings with cystic leukoencephalopathy and megalencephaly.","volume":"15","author":"Yalinkaya","year":"2000","journal-title":"J Child Neurol"},{"key":"R71-2-20210213","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s004010050510","article-title":"Histopathology of infantile-onset spongiform leukoencephalopathy with a discrepantly mild clinical course.","volume":"92","author":"van der Knaap","year":"1996","journal-title":"Acta Neuropathol (Berl)"},{"key":"R72-2-20210213","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/humu.20332","article-title":"Mejaski-Bosnjakvgiven-names\/, et al. Megalencephalic leukoencephalopathy with subcortical cysts: an update and extended mutation analysis of MLC1.","volume":"27","author":"Boor","year":"2006","journal-title":"Hum Mutat"},{"key":"R73-2-20210213","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/01.WNL.0000115106.88813.5B","article-title":"Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation.","volume":"62","author":"Gorospe","year":"2004","journal-title":"Neurology"},{"key":"R74-2-20210213","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1148\/radiology.213.1.r99se01121","article-title":"Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach.","volume":"213","author":"van der Knaap","year":"1999","journal-title":"Radiology"},{"key":"R75-2-20210213","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.410350314","article-title":"Childhood ataxia with diffuse central nervous system hypomyelination.","volume":"35","author":"Schiffmann","year":"1994","journal-title":"Ann Neurol"},{"key":"R76-2-20210213","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.1227","article-title":"Myelinopathia centralis diffusa (vanishing white matter disease): evidence of apoptotic oligodendrocyte degeneration in early lesion development.","volume":"50","author":"Bruck","year":"2001","journal-title":"Ann Neurol"},{"key":"R77-2-20210213","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.410240403","article-title":"Leukoencephalopathy among native Indian infants in northern Quebec and Manitoba.","volume":"24","author":"Black","year":"1998","journal-title":"Ann Neurol"},{"key":"R78-2-20210213","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/ana.10339","article-title":"Cree leukoencephalopathy and CACH\/VWM disease are allelic at the EIF2B5 locus.","volume":"52","author":"Fogli","year":"2002","journal-title":"Ann Neurol"},{"key":"R79-2-20210213","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ana.410410515","article-title":"Leukodystrophy in individuals with ovarian dysgenesis.","volume":"41","author":"Schiffmann","year":"1997","journal-title":"Ann Neurol"},{"key":"R80-2-20210213","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1086\/375404","article-title":"Ovarian failure related to eukaryotic initiation factor 2B mutations.","volume":"72","author":"Fogli","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R81-2-20210213","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(06)70440-9","article-title":"Vanishing white matter disease.","volume":"5","author":"van der Knaap","year":"2006","journal-title":"Lancet Neurol"},{"key":"R82-2-20210213","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2008-1071551","article-title":"Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy.","volume":"24","author":"Hanefeld","year":"1993","journal-title":"Neuropediatrics"},{"key":"R83-2-20210213","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.ejhg.5201189","article-title":"Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.","volume":"12","author":"Fogli","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"R84-2-20210213","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.jnen.0000228201.27539.50","article-title":"Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease.","volume":"65","author":"van Kollenburg","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"R85-2-20210213","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1212\/01.WNL.0000123259.67815.DB","article-title":"The effect of genotype on the natural history of eIF2B-related leukodystrophies.","volume":"62","author":"Fogli","year":"2004","journal-title":"Neurology"},{"key":"R86-2-20210213","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1086\/379524","article-title":"eIF2B related disorders: antenatal onset and involvement of multiple organs.","volume":"73","author":"van der Knaap","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R87-2-20210213","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ana.10112","article-title":"Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.","volume":"53","author":"van der Knaap","year":"2002","journal-title":"Ann Neurol"},{"key":"R88-2-20210213","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ymgme.2005.10.019","article-title":"Childhood ataxia with CNS hypomyelination\/vanishing white matter diseaseVa common leukodystrophy caused by abnormal control of protein synthesis.","volume":"88","author":"Schiffmann","year":"2006","journal-title":"Mol Genet Metab"},{"key":"R89-2-20210213","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.20671","article-title":"Progressive cavitating leukoencephalopathy: a novel childhood disease.","volume":"58","author":"Naidu","year":"2005","journal-title":"Ann Neurol"},{"key":"R90-2-20210213","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/6772","article-title":"Mutant NDUFV1 subunit of mitochondrial complex 1 causes leukodystrophy and myoclonic epilepsy.","volume":"21","author":"Schuelke","year":"1999","journal-title":"Nat Genet"},{"key":"R91-2-20210213","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2004.09.008","article-title":"White matter involvement in mitochondrial diseases.","volume":"84","author":"Lerman-Sagie","year":"2005","journal-title":"Mol Genet Metab"},{"key":"R92-2-20210213","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ana.20746","article-title":"Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion.","volume":"59","author":"Pineda","year":"2006","journal-title":"Ann Neurol"},{"key":"R93-2-20210213","first-page":"809","article-title":"Neuroradiologic findings in fucosidosis, a rare lysosomal storage disease.","volume":"16","author":"Provenzale","year":"1995","journal-title":"AJNR Am J Neuroradiol"},{"key":"R94-2-20210213","first-page":"777","article-title":"MR brain imaging of fucosidosis type I.","volume":"22","author":"Galluzzi","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"key":"R95-2-20210213","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/WNL.55.1.99","article-title":"Central and peripheral nervous system dysfunction in the clinical variation of Salla disease.","volume":"55","author":"Varho","year":"2000","journal-title":"Neurology"},{"key":"R96-2-20210213","first-page":"433","article-title":"Brain involvement in Salla disease.","volume":"20","author":"Sonninen","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"key":"R97-2-20210213","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00234-002-0900-1","article-title":"A case of Salla disease with involvement of the cerebellar white matter.","volume":"45","author":"Linnankivi","year":"2003","journal-title":"Neuroradiology"},{"key":"R98-2-20210213","first-page":"398","article-title":"Infantile sialic acid storage disease: serial ultrasound and magnetic resonance imaging features.","volume":"24","author":"Parazzini","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"R99-2-20210213","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/WNL.52.8.1668","article-title":"A new metabolite contributing to N-acetyl signal in 1H MRS of the brain in Salla disease.","volume":"52","author":"Varho","year":"1999","journal-title":"Neurology"},{"key":"R100-2-20210213","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2004-815788","article-title":"Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (Infantile CLN1) at different stages of the disease.","volume":"35","author":"Vanhanen","year":"2004","journal-title":"Neuropediatrics"},{"key":"R101-2-20210213","first-page":"1373","article-title":"MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis.","volume":"19","author":"Seitz","year":"1998","journal-title":"AJNR Am J Neuroradiol"},{"key":"R102-2-20210213","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.bmt.1701826","article-title":"Niemann-Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation.","volume":"24","author":"Hsu","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R103-2-20210213","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/jnnp.65.1.72","article-title":"Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease.","volume":"65","author":"Tedeschi","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R104-2-20210213","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/mds.10541","article-title":"Adult-onset Niemann-Pick type C disease: a clinical, neuroimaging, and molecular genetic study.","volume":"18","author":"Battisti","year":"2003","journal-title":"Mov Disord"},{"key":"R105-2-20210213","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0887-8994(93)90073-L","article-title":"Infantile galactosialidosis presenting with congenital adrenal hyperplasia and renal hypertension.","volume":"9","author":"Kyllerman","year":"1993","journal-title":"Pediatr Neurol"},{"key":"R106-2-20210213","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/08830738030180061201","article-title":"Infantile Sandhoff's disease: multivoxel magnetic resonance spectroscopy findings.","volume":"18","author":"Alkan","year":"2003","journal-title":"J Child Neurol"},{"key":"R107-2-20210213","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1212\/01.WNL.0000143057.25471.4F","article-title":"Adult -mannosidosis. Clinical progression in the absence of demyelination.","volume":"63","author":"Gutschalk","year":"2004","journal-title":"Neurology"},{"key":"R108-2-20210213","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.51.2.565","article-title":"Mucolipidosis type IV: characteristic MRI findings.","volume":"51","author":"Frei","year":"1998","journal-title":"Neurology"},{"key":"R109-2-20210213","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10545-006-0415-8","article-title":"The aetiology of neurological complications of organic acidemias-a role for the blood-brain barrier.","volume":"29","author":"Kolker","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"R110-2-20210213","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01800354","article-title":"Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids: implications for treatment: associations with CNS dysmyelination.","volume":"15","author":"Treacy","year":"1992","journal-title":"J Inherit Metab Dis"},{"key":"R111-2-20210213","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2004.01.016","article-title":"Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.","volume":"82","author":"Schonberger","year":"2004","journal-title":"Mol Genet Metab"},{"key":"R112-2-20210213","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1172\/JCI5017","article-title":"Large neutral amino acids block phenylalanine transport into the brain in patients with phenylketonuria.","volume":"103","author":"Pietz","year":"1999","journal-title":"J Clin Invest"},{"key":"R113-2-20210213","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archneur.62.4.666","article-title":"L-2-hydroxyglutaric aciduria: clinical, neuroimaging and neuropathological findings.","volume":"62","author":"Seijo-Martinez","year":"2005","journal-title":"Arch Neurol"},{"key":"R115-2-20210213","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ana.20280","article-title":"3-Hydroxy-3-methylglutaryl CoA lyase deficiency in an adult with leukoencephalopathy.","volume":"56","author":"Bischof","year":"2004","journal-title":"Ann Neurol"},{"issue":"suppl 1","key":"R116-2-20210213","first-page":"72","article-title":"Multiple acyl-CoA dehydrogenase deficiency: acquired leukodystrophy treated D with, L-3-hydroxybutyrate.","volume":"24","author":"van Hove","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"R117-2-20210213","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/BF00711898","article-title":"Physiology and pathophysiology of organic acids in cerebrospinal fluid.","volume":"16","author":"Hoffman","year":"1993","journal-title":"J Inherit Metab Dis"},{"key":"R118-2-20210213","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ana.10456","article-title":"A new leukodystrophy, with brainstem and spinal cord involvement and high lactate.","volume":"53","author":"van der Knaap","year":"2003","journal-title":"Ann Neurol"},{"key":"R119-2-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2003-43548","article-title":"Five patients with a recently described novel leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate.","volume":"35","author":"Serkov","year":"2004","journal-title":"Neuropediatrics"},{"key":"R120-2-20210213","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/01.WNL.0000134658.35601.41","article-title":"Five new cases of a recently described leukoencephalopathy with high brain lactate.","volume":"63","author":"Linnankivi","year":"2004","journal-title":"Neurology"},{"key":"R121-2-20210213","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/jnnp.2005.078568","article-title":"Adult onset leucoencephalopathy with brain stem and spinal cord involvement and normal lactate.","volume":"77","author":"Petzolf","year":"2006","journal-title":"J Neuro Neurosurg Psychiatry"},{"key":"R122-2-20210213","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1566524024605815","article-title":"The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.","volume":"2","author":"Moses","year":"2002","journal-title":"Curr Mol Med"},{"key":"R123-2-20210213","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jpeds.2004.07.024","article-title":"Neonatal type IV glycogen storage disease associated with \"null\" mutations in glycogen branching enzyme 1.","volume":"145","author":"Janecke","year":"2004","journal-title":"J Pediatr"},{"key":"R124-2-20210213","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.nmd.2003.12.006","article-title":"Fatal infantile neuromuscular presentation of glycogen storage disease type IV.","volume":"17","author":"Tay","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"R125-2-20210213","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mus.10520","article-title":"Adult polyglucosan body disease: case description of an expanding genetic and clinical syndrome.","volume":"29","author":"Klein","year":"2004","journal-title":"Muscle Nerve"},{"key":"R126-2-20210213","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archneur.1971.00490010079011","article-title":"Presenile dementia with \"Lafora-like\" intraneuronal inclusions.","volume":"25","author":"Suzuki","year":"1971","journal-title":"Arch Neurol"},{"key":"R127-2-20210213","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archneur.1994.00540130124021","article-title":"Dementia of adult polyglucosan body disease. Evidence of cortical and subcortical dysfunction.","volume":"51","author":"Rifai","year":"1994","journal-title":"Arch Neurol"},{"key":"R128-2-20210213","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002340000425","article-title":"Extensive white-matter changes in case of adult polyglucosan body disease.","volume":"43","author":"Berkhoff","year":"2001","journal-title":"Neuroradiology"},{"key":"R129-2-20210213","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.410330114","article-title":"Glycogen branching enzyme deficiency in adult polyglucosan body disease.","volume":"33","author":"Bruno","year":"1993","journal-title":"Ann Neurol"},{"key":"R130-2-20210213","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/1531-8249(200004)47:4<536::AID-ANA22>3.0.CO;2-K","article-title":"Novel missense mutations in the glucogen-branching enzyme gene in adult polyglucosan body disease.","volume":"47","author":"Ziemssen","year":"2000","journal-title":"Ann Neurol"},{"key":"R131-2-20210213","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ana.410440604","article-title":"Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen branching enzyme gene.","volume":"44","author":"Lossos","year":"1998","journal-title":"Ann Neurol"},{"key":"R132-2-20210213","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jmg.38.10.649","article-title":"The expanding phenotype of laminin 2 chain (merosin)abnormalities; case series and review.","volume":"38","author":"Jones","year":"2001","journal-title":"J Med Genet"},{"key":"R133-2-20210213","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s002340050689","article-title":"Congenital muscular dystrophy with merosin deficiency: MRI findings in five patients.","volume":"40","author":"Farina","year":"1998","journal-title":"Neuroradiology"},{"key":"R134-2-20210213","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0960-8966(98)00110-2","article-title":"Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging.","volume":"9","author":"Philpot","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"R135-2-20210213","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nmd.2004.06.009","article-title":"The congenital muscular dystrophies in 2004: a century of exciting progress.","volume":"14","author":"Muntoni","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"R136-2-20210213","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ng1095-216","article-title":"Mutations in the laminin 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy.","volume":"11","author":"Helbling-Leclerc","year":"1995","journal-title":"Nat Genet"},{"key":"R137-2-20210213","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMcpc069026","article-title":"Case records of the Massachusetts General Hospital. Case 35-2006: a newborn baby with hypotonia.","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"R138-2-20210213","first-page":"1","article-title":"Oligophrenia in combination with congenital ichthyosis and spastic disorders.","volume":"113","author":"Sjogren","year":"1957","journal-title":"Acta Psychiatr Neurol Scand Suppl"},{"key":"R139-2-20210213","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/brain\/124.7.1426","article-title":"Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjogren-Larsson syndrome.","volume":"124","author":"Willemsen","year":"2001","journal-title":"Brain"},{"key":"R140-2-20210213","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3476(89)80070-8","article-title":"Sjogren-Larsson syndrome: Inherited defect in the fatty alcohol cycle.","volume":"115","author":"Rizzo","year":"1989","journal-title":"J Pediatr"},{"key":"R141-2-20210213","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1212\/WNL.52.7.1345","article-title":"Sjogren-Larsson syndrome. Clinical and MRI\/MRS findings in the FALDH deficient patients.","volume":"52","author":"van Domburg","year":"1999","journal-title":"Neurology"},{"key":"R142-2-20210213","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/7010.2006.00300","article-title":"Proton magnetic resonance spectroscopy findings and clinical effects of Montelukast sodium in a case with Sjogren-Larsson syndrome.","volume":"21","author":"Pirgon","year":"2006","journal-title":"J Child Neurol"},{"key":"R143-2-20210213","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0887-8994(97)00192-6","article-title":"Sjogren-Larsson syndrome: postmortem brain abnormalities.","volume":"18","author":"Yamaguchi","year":"1998","journal-title":"Pediatr Neurol"},{"key":"R144-2-20210213","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.gt.3302743","article-title":"Restoration of fatty aldehyde dehydrogenase deficiency in Sjogren-Larsson syndrome.","volume":"13","author":"Haug","year":"2006","journal-title":"Gene Ther"},{"key":"R145-2-20210213","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1005508205450","article-title":"Molecular basis of Sjogren-Larsson syndrome: frequency of the 197-1298delGA and 943CT mutation in 29 patients.","volume":"22","author":"IJlst","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"R146-2-20210213","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0022-3476(05)81369-1","article-title":"Unsuccessful dietary treatment of Sjogren-Larsson syndrome.","volume":"124","author":"Maaswinkel-Mooij","year":"1994","journal-title":"J Pediatr"},{"key":"R147-2-20210213","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s004310100838","article-title":"Clinical and biochemical effects on zileuton in patients with the Sjogren-Larsson syndrome.","volume":"12","author":"Willemsen","year":"2001","journal-title":"Eur J Pediatr"},{"key":"R148-2-20210213","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymgme.2006.05.009","article-title":"Bezafibrate induces FALDH in human fibroblasts; implications for Sjogren-Larsson syndrome.","volume":"89","author":"Gloerich","year":"2006","journal-title":"Mol Genet Metab"},{"key":"R149-2-20210213","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10545-005-0115-9","article-title":"A novel assay for the prenatal diagnosis of Sjogren-Larsson syndrome.","volume":"28","author":"van den Brink","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"R150-2-20210213","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1023\/A:1021211520034","article-title":"Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis.","volume":"25","author":"Clayton","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"R151-2-20210213","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archneur.57.4.520","article-title":"Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis.","volume":"57","author":"Verrips","year":"2000","journal-title":"Arch Neurol"},{"key":"R152-2-20210213","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1023\/A:1012981019336","article-title":"Cerebrotendinous xanthomatosis: heterogeneity of clinical phenotype with evidence of previously undescribed ophthalmological findings.","volume":"24","author":"Dotti","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"R153-2-20210213","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0733-8619(18)30828-4","article-title":"Cerebrotendinous xanthomatosis.","volume":"7","author":"Berginer","year":"1989","journal-title":"Neurol Clin"},{"key":"R154-2-20210213","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/brain\/123.5.908","article-title":"Clinical and molecular characteristics of patients with cerebrotendinous xanthomatosis.","volume":"123","author":"Verrips","year":"2000","journal-title":"Brain"},{"key":"R155-2-20210213","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/brain\/124.1.121","article-title":"Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis.","volume":"124","author":"DeStefano","year":"2001","journal-title":"Brain"},{"key":"R156-2-20210213","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/brain\/122.8.1589","article-title":"Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis.","volume":"122","author":"Verrips","year":"1999","journal-title":"Brain"},{"key":"R157-2-20210213","first-page":"495","article-title":"Quantification of brain damage in cerebrotendinous xanthomatosis with magnetization transfer MR imaging.","volume":"24","author":"Inglese","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"R158-2-20210213","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archneur.1968.00480010065004","article-title":"Cerebrotendinous xanthomatosis: the storage of cholestanol within the nervous system.","volume":"19","author":"Menkes","year":"1968","journal-title":"Arch Neurol"},{"key":"R159-2-20210213","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1194\/jlr.M600113-JLR200","article-title":"Cholestanol metabolism in patients with cerebrotendinous xanthomatosis; absorption, turnover and tissue deposition.","volume":"48","author":"Bhattacharyya","year":"2007","journal-title":"J Lipid Res"},{"key":"R160-2-20210213","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10072-006-0618-7","article-title":"Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene.","volume":"27","author":"Gallus","year":"2006","journal-title":"Neurol Sci"},{"key":"R161-2-20210213","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM198412273112601","article-title":"Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.","volume":"311","author":"Berginer","year":"1984","journal-title":"N Engl J Med"},{"key":"R162-2-20210213","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1212\/WNL.41.3.434","article-title":"Cerebrotendinous xanthomatosis; treatments with simvastatin, lovastatin and chenodeoxycholic acid in 3 siblings.","volume":"41","author":"Peynet","year":"1991","journal-title":"Neurology"},{"key":"R163-2-20210213","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s004310050818","article-title":"Treatment and follow-up of children with cerebrotendinous xanthomatosis.","volume":"157","author":"van Heijst","year":"1998","journal-title":"Eur J Pediatr"},{"key":"R164-2-20210213","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1212\/WNL.44.11.2218","article-title":"Treatment of cerebrotendinous xanthomatosis.","volume":"44","author":"Federico","year":"1994","journal-title":"Neurology"},{"key":"R165-2-20210213","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/archneur.62.9.1459","article-title":"Cerebrotendinous xanthomatosis. Possible higher prevalence than previously recognized.","volume":"62","author":"Lorinez","year":"2005","journal-title":"Arch Neurol"},{"key":"R166-2-20210213","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ana.410440506","article-title":"The phenotypic spectrum of CADASIL: Clinical findings in 102 cases.","volume":"44","author":"Dichgans","year":"1998","journal-title":"Ann Neurol"},{"key":"R167-2-20210213","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00005072-199709000-00001","article-title":"CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.","volume":"56","author":"Ruchoux","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"R168-2-20210213","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp.70.3.285","article-title":"Cerebral autosomal arteriopathy with subcortical infarcts and leukoencephalopathy: from stroke to vessel wall physiology.","volume":"70","author":"Bousser","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R169-2-20210213","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1212\/WNL.50.5.1505","article-title":"Acetazolamide-responsive migraine in CADASIL.","volume":"50","author":"Weller","year":"1998","journal-title":"Neurology"},{"key":"R170-2-20210213","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1212\/01.WNL.0000055927.22611.EB","article-title":"Cholinergic denervation in a pure multi-infarct state. Observations on CADASIL.","volume":"60","author":"Melusam","year":"2003","journal-title":"Neurology"},{"key":"R171-2-20210213","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000117096","article-title":"Familial young-adult onset arteriosclerotic leukoencephalopathy with alopecia and lumbago without arterial hypertension.","volume":"35","author":"Fukutake","year":"1995","journal-title":"Eur Neurol"},{"key":"R172-2-20210213","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/WNL.49.5.1322","article-title":"Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS).","volume":"49","author":"Jen","year":"1997","journal-title":"Neurology"},{"key":"R173-2-20210213","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0161-6420(88)33131-3","article-title":"Cerebroretinal vasculopathy: a new hereditary syndrome.","volume":"95","author":"Grand","year":"1988","journal-title":"Ophthalmology"},{"key":"R174-2-20210213","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/brain\/121.2.303","article-title":"Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon.","volume":"121","author":"Terwindt","year":"1998","journal-title":"Brain"},{"key":"R175-2-20210213","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.60.1.57","article-title":"Hereditary infantile hemiparesis, retinal arteriolar tortuosity and leukoencephalopathy.","volume":"60","author":"Vahedi","year":"2003","journal-title":"Neurology"},{"key":"R176-2-20210213","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410150109","article-title":"A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis.","volume":"15","author":"Aicardi","year":"1984","journal-title":"Ann Neurol"},{"key":"R177-2-20210213","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/ana.410440608","article-title":"Aicardi-Goutieres syndrome: an update and results of interferon alpha studies.","volume":"44","author":"Goutieres","year":"1998","journal-title":"Ann Neurol"},{"key":"R178-2-20210213","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/088307380101601009","article-title":"Aicardi-Goutieres syndrome in siblings.","volume":"16","author":"Koul","year":"2001","journal-title":"J Child Neurol"},{"key":"R179-2-20210213","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ng1842","article-title":"Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection.","volume":"38","author":"Crow","year":"2006","journal-title":"Nat Genet"},{"key":"R180-2-20210213","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ng1845","article-title":"Mutations in the gene encoding the 3-5 DNA exonuclease TREX I cause Aicardi-Goutieres syndrome at the AGS1 locus.","volume":"38","author":"Crow","year":"2006","journal-title":"Nat Genet"},{"key":"R181-2-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/adc.11.61.1","article-title":"Dwarfism with retinal atrophy and deafness.","volume":"11","author":"Cockayne","year":"1936","journal-title":"Arch Dis Child"},{"key":"R182-2-20210213","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/adc.21.105.52","article-title":"Dwarfism with retinal atrophy and deafness.","volume":"21","author":"Cockayne","year":"1946","journal-title":"Arch Dis Child"},{"key":"R183-2-20210213","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ajmg.1320420115","article-title":"Cockayne syndrome. Review of 140 cases.","volume":"42","author":"Nance","year":"1992","journal-title":"Am J Med Genet"},{"key":"R184-2-20210213","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/08830738060210110101","article-title":"Cockayne syndrome in adults: Review with clinical and pathologic study of a new case.","volume":"21","author":"Rapin","year":"2006","journal-title":"J Child Neurol"},{"key":"R185-2-20210213","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9394(14)74486-1","article-title":"Ocular finding in Cockayne syndrome.","volume":"114","author":"Traboulsi","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"R186-2-20210213","doi-asserted-by":"crossref","first-page":"10499","DOI":"10.1073\/pnas.90.22.10499","article-title":"Preferential repair of ionizing radiation-induced drainage in the transcribed stand of an active human gene is defective in Cockayne syndrome.","volume":"90","author":"Leaden","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R187-2-20210213","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jmg.30.8.679","article-title":"Cockayne's syndrome: correlation of clinical features with cellular sensitivity of RNA synthesis to UV irradiation.","volume":"30","author":"Lehmann","year":"1993","journal-title":"J Med Genet"},{"key":"R188-2-20210213","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0092-8674(95)90028-4","article-title":"The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH.","volume":"82","author":"Henning","year":"1995","journal-title":"Cell"},{"key":"R189-2-20210213","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/301686","article-title":"Molecular analysis of mutations in the CSB (ERCC6) gene in patients with Cockayne syndrome.","volume":"62","author":"Mallery","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R190-2-20210213","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/jmg.37.7.553","article-title":"Cockayne syndrome associated with low CSF 5-hydroxyindole acetic acid levels.","volume":"37","author":"Ellaway","year":"2000","journal-title":"J Med Genet"},{"key":"R191-2-20210213","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/pd.1541","article-title":"Prenatal diagnosis of the Cockayne syndrome: survey of 15 years experience.","volume":"26","author":"Kleijer","year":"2006","journal-title":"Prenat Diagn"},{"key":"R192-2-20210213","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.57.1.127","article-title":"Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.","volume":"57","author":"Hagerman","year":"2001","journal-title":"Neurology"},{"key":"R193-2-20210213","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1474-4422(06)70676-7","article-title":"Fragile-X syndrome and fragile X-associated tremor\/ataxia syndrome: two faces of FMR1.","volume":"6","author":"Jacquement","year":"2007","journal-title":"Lancet Neurology"},{"key":"R194-2-20210213","first-page":"1757","article-title":"Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction.","volume":"23","author":"Brunberg","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"R195-2-20210213","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/brain\/awh683","article-title":"Neuropathology of fragile X-associated tremor\/ataxia syndrome (FXTAS).","volume":"129","author":"Greco","year":"2006","journal-title":"Brain"},{"key":"R196-2-20210213","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1212\/01.wnl.0000239837.57475.3a","article-title":"Molecular and imaging correlates of the fragile X-associated tremor\/ataxia syndrome.","volume":"67","author":"Cohen","year":"2006","journal-title":"Neurology"},{"key":"R197-2-20210213","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.291.4.460","article-title":"Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population.","volume":"291","author":"Jacquemont","year":"2004","journal-title":"JAMA"},{"key":"R198-2-20210213","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1136\/jmg.2004.024190","article-title":"Spastic paraparesis, cerebellar ataxia, and intention tremor: a severe variant of FXTAS?","volume":"42","author":"Jacquemont","year":"2005","journal-title":"J Med Genet"},{"key":"R199-2-20210213","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/mds.21001","article-title":"Symptomatic treatment in the fragile X-associated tremor\/ataxia syndrome.","volume":"21","author":"Hall","year":"2006","journal-title":"Mov Disord"},{"key":"R200-2-20210213","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.ejhg.5201318","article-title":"Screening for FXTAS.","volume":"13","author":"Jacquement","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"R201-2-20210213","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM198410113111504","article-title":"Hereditary adult-onset leukodystrophy simulating chronic progressive multiple sclerosis.","volume":"311","author":"Eldridge","year":"1984","journal-title":"N Engl J Med"},{"key":"R202-2-20210213","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/archneur.1988.00520330094015","article-title":"Computed tomography and magnetic resonance imaging in a newly described adult-onset leukodystrophy.","volume":"45","author":"Schwankhaus","year":"1988","journal-title":"Arch Neurol"},{"key":"R203-2-20210213","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archneur.1994.00540200033013","article-title":"Clinical and pathological features of an autosomal dominant, adult-onset leukodystrophy simulating chronic progressive multiple sclerosis.","volume":"51","author":"Schwankhaus","year":"1994","journal-title":"Arch Neurol"},{"key":"R204-2-20210213","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ajmg.b.30342","article-title":"Adult-onset autosomal dominant leukodystrophy with autonomic symptoms restricted to 1.5 Mbp on chromosome 5q23.","volume":"141","author":"Marklund","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R205-2-20210213","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ng1872","article-title":"Lamin B1 duplications cause autosomal dominant leukodystrophy.","volume":"38","author":"Padiath","year":"2006","journal-title":"Nat Genet"},{"issue":"suppl 314","key":"R206-2-20210213","first-page":"7","article-title":"Hereditary diffuse leukoencephalopathy with spheroids.","volume":"69","author":"Axelsson","year":"1984","journal-title":"Acta Psychiatr Scand"},{"key":"R207-2-20210213","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/jnnp.2003.028431","article-title":"Leukoencephalopathy with neuroaxonal spheroids (LENAS) presenting as the cerebellar subtype of multiple system atrophy.","volume":"75","author":"More-de-Casillas","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R208-2-20210213","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1212\/WNL.54.2.463","article-title":"Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids.","volume":"54","author":"van der Knaap","year":"2000","journal-title":"Neurology"},{"key":"R209-2-20210213","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/jnnp.74.9.1345","article-title":"Hereditary diffuse leukoencephalopathy with spheroids.","volume":"74","author":"Hancock","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R210-2-20210213","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/81701","article-title":"The gene encoding gigaxonin, a new member of the cytoskeletal BTB\/Kelch repeat family, is mutated in giant axonal neuropathy.","volume":"26","author":"Bomont","year":"2000","journal-title":"Nat Genet"},{"key":"R211-2-20210213","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/brain\/awl110","article-title":"A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34.","volume":"129","author":"Thiffault","year":"2006","journal-title":"Brain"},{"key":"R212-2-20210213","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp.2005.077982","article-title":"Vacuolar leucoencephalopathy and pulvinar sign in association with coeliac disease.","volume":"78","author":"Ryan","year":"2006","journal-title":"J Neurol Neurosurg Psych"},{"key":"R214-2-20210213","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1212\/WNL.54.5.1123","article-title":"Dural arteriovenous fistula mimicking leukoencephalopathy.","volume":"54","author":"Ikeda","year":"2000","journal-title":"Neurology"},{"key":"R215-2-20210213","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1542\/peds.2005-1866","article-title":"Natural history of brain lesions in extremely preterm infants studied with serial magnetic resonance imaging from birth and neurodevelopmental assessment.","volume":"118","author":"Dyet","year":"2006","journal-title":"Pediatric"},{"key":"R216-2-20210213","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa053792","article-title":"Neonatal MRI to predict neurodevelopmental outcomes in preterm infants.","volume":"355","author":"Woodward","year":"2006","journal-title":"N Engl J Med"},{"key":"R217-2-20210213","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/WNL.59.7.1108","article-title":"Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities.","volume":"59","author":"O'Riordan","year":"2002","journal-title":"Neurology"},{"key":"R218-2-20210213","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1212\/01.wnl.0000230133.11951.75","article-title":"A new type of leukoencephalopathy with metaphyseal chondrodysplasia maps to Xq25-q27.","volume":"67","author":"Neubauer","year":"2006","journal-title":"Neurology"},{"key":"R219-2-20210213","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.ejhg.5201128","article-title":"Molecular characterization of an 11q14.3 microdeletion associated with leukodystrophy.","volume":"12","author":"Goizet","year":"2004","journal-title":"Eur J Hum Genet"}],"container-title":["Topics in Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002142-200608000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:32:09Z","timestamp":1786033929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002142-200608000-00002"}},"subtitle":["Clinical and Genetic Aspects"],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":216,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/rmr.0b013e31804c99d4","relation":{},"ISSN":["0899-3459"],"issn-type":[{"value":"0899-3459","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}